ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Catalent says it will expand its oral-dose drug development and manufacturing services with the acquisition of Metrics Contract Services from Mayne Pharma for $475 million. Metrics specializes in production and packaging of high-potency drugs. Its Greenville, North Carolina, facility features 16 manufacturing suites and two packaging lines with an annual production capacity of about 1 billion oral solid-dose units. Catalent already operates a controlled-release oral-dose drug plant in Winchester, Kentucky, and a softgel facility in St. Petersburg, Florida.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter